4746 related articles for article (PubMed ID: 415083)
41. B16 melanoma in C57BL-6J mice: kinetics and effects of heterologous serum.
Hill GJ; Littlejohn K
J Surg Oncol; 1971; 3(1):1-7. PubMed ID: 5093800
[No Abstract] [Full Text] [Related]
42. Dopachrome conversion: a possible control point in melanin biosynthesis.
Körner AM; Pawelek J
J Invest Dermatol; 1980 Aug; 75(2):192-5. PubMed ID: 6774031
[No Abstract] [Full Text] [Related]
43. Two types of melanogenesis in monolayer cultures of melanoma cells.
Oikawa A; Nakayasu M; Claunch C; Tchen TT
Cell Differ; 1972 Aug; 1(3):149-55. PubMed ID: 4209534
[No Abstract] [Full Text] [Related]
44. Transcriptionally targeted gene therapy.
Hart IR
Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():19-25. PubMed ID: 8815006
[No Abstract] [Full Text] [Related]
45. Melanogenesis and the generation of cytotoxic molecules during insect cellular immune reactions.
Nappi AJ; Vass E
Pigment Cell Res; 1993 Jun; 6(3):117-26. PubMed ID: 8234196
[No Abstract] [Full Text] [Related]
46. Neural differentiation in the OTT-6050 mouse teratoma. Production of a tumor fraction showing melanogenesis in neuroepithelial cells after centrifugal elutriation.
VandenBerg SR; Hess JR; Herman MM; DeArmond SJ; Halks-Miller M; Rubinstein LJ
Virchows Arch A Pathol Anat Histol; 1981; 392(3):295-308. PubMed ID: 7269229
[No Abstract] [Full Text] [Related]
47. The cell nucleus of cultured melanoma cells as a source of ultraweak photon emission.
Niggli HJ
Naturwissenschaften; 1996 Jan; 83(1):41-4. PubMed ID: 8637607
[No Abstract] [Full Text] [Related]
48. Growth inhibition of re-challenge B16 melanoma transplant by conjugates of melanogenesis substrate and magnetite nanoparticles as the basis for developing melanoma-targeted chemo-thermo-immunotherapy.
Takada T; Yamashita T; Sato M; Sato A; Ono I; Tamura Y; Sato N; Miyamoto A; Ito A; Honda H; Wakamatsu K; Ito S; Jimbow K
J Biomed Biotechnol; 2009; 2009():457936. PubMed ID: 19830247
[TBL] [Abstract][Full Text] [Related]
49. Increased in vitro radio-sensitivity of malignant melanoma induced by the in vivo administration of chlorpromazine.
Cooper M; Mishima Y
Br J Dermatol; 1972 May; 86(5):491-4. PubMed ID: 5039121
[No Abstract] [Full Text] [Related]
50. Melanin binding properties of iodoquine.
Blois MS
J Invest Dermatol; 1968 Mar; 50(3):250-3. PubMed ID: 5644898
[No Abstract] [Full Text] [Related]
51. [On melanogenesis in human tumor cells].
Overbeck L; Philipp E
Naturwissenschaften; 1968 May; 55(5):232. PubMed ID: 5702832
[No Abstract] [Full Text] [Related]
52. An analysis of skin tests and their relationship to recurrence and survival in stage III and stage IV melanoma patients.
Lee ET; Ishmael DR; Bottomley RH; Murray JL
Cancer; 1982 Jun; 49(11):2336-41. PubMed ID: 7074548
[TBL] [Abstract][Full Text] [Related]
53. Proliferation of alloreactive human natural killer cells independent of specific allogeneic stimulation.
Warren HS; Kinnear BF; Witt CS; Christiansen FT
Int Immunol; 1994 Apr; 6(4):507-13. PubMed ID: 8018592
[TBL] [Abstract][Full Text] [Related]
54. Tumor-specific markers of malignant melanoma.
Hearing VJ
Am J Dermatopathol; 1981; 3(4):411-6. PubMed ID: 7337195
[TBL] [Abstract][Full Text] [Related]
55. Multivalent melanotropic peptide and fluorescent macromolecular conjugates: new reagents for characterization of melanotropin receptors.
Sharma SD; Granberry ME; Jiang J; Leong SP; Hadley ME; Hruby VJ
Bioconjug Chem; 1994; 5(6):591-601. PubMed ID: 7873662
[TBL] [Abstract][Full Text] [Related]
56. Anti-tumour activity of the methanol extract Ervatamia heyneana (NSC B668619).
Chitnis MP; Bhatia KG; Phatak MK
Indian J Exp Biol; 1979 Feb; 17(2):212. PubMed ID: 478589
[No Abstract] [Full Text] [Related]
57. Preparation of two dosage forms containing antitumor prostaglandin and their antitumor effect in vitro and in vivo: Lipiodol solution for i.a. administration and lipid microspheres for i.p. or i.v. administration.
Shoji F; Masahiro N; Yoshikazu T; Masanori F
Adv Exp Med Biol; 1997; 400B():955-61. PubMed ID: 9547652
[No Abstract] [Full Text] [Related]
58. [Macular combined malformation (hamartoma) of the retina and retinal pigment epithelium].
Wiechens B; Amm M
Ophthalmologe; 1996 Dec; 93(6):724-8. PubMed ID: 9081532
[TBL] [Abstract][Full Text] [Related]
59. The emergence of non-cytolytic NK1.1+ T cells in the long-term culture of murine tumour-infiltrating lymphocytes: a possible role of transforming growth factor-beta.
Tamada K; Harada M; Ito O; Takenoyama M; Mori T; Matsuzaki G; Nomoto K
Immunology; 1996 Dec; 89(4):627-35. PubMed ID: 9014832
[TBL] [Abstract][Full Text] [Related]
60. Expression of platelet-derived growth factor (PDGF)-A, PDGF-B and the PDGF-alpha receptor, but not the PDGF-beta receptor, in human malignant melanoma in vivo.
Barnhill RL; Xiao M; Graves D; Antoniades HN
Br J Dermatol; 1996 Dec; 135(6):898-904. PubMed ID: 8977709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
